Exposure of Hepatocellular Carcinoma Cells to Ankaferd Blood Stopper (R) Alters Cell Death Signaling Networks Confirmed by Oncoproteomic and Genomic Profiling Studies


NENNİ M., ÖNCÜL S., ERCAN A., ÇELEBİER M., SÜSLÜ İ., HAZNEDAROĞLU İ. C.

CURRENT TRADITIONAL MEDICINE, vol.7, no.2, pp.223-235, 2021 (ESCI) identifier identifier

Abstract

Background: Ankaferd Blood Stopper (R) is a commercially available herbal extract with potent blood-stopping property and is clinically used to treat immediate dental, dermal, external and internal bleeding. Its possible anti-neoplastic effect or whether it ingenerates drug resistance in cells has not been previously scrutinized.